The use of STarT back screening tool to predict functional disability outcomes in patients receiving physical therapy for low back pain.


Journal

The spine journal : official journal of the North American Spine Society
ISSN: 1878-1632
Titre abrégé: Spine J
Pays: United States
ID NLM: 101130732

Informations de publication

Date de publication:
04 2019
Historique:
received: 22 07 2018
revised: 02 10 2018
accepted: 02 10 2018
pubmed: 12 10 2018
medline: 20 2 2020
entrez: 12 10 2018
Statut: ppublish

Résumé

The STarT Back Screening Tool (SBST) categorizes risk of future disability in patients with low back pain (LBP). Previous studies evaluating the use of SBST in physical therapy (PT) populations do not reflect the ethnic and socioeconomic diversity occurring in clinical practice and lack statistical power to evaluate factors associated with outcomes within each SBST risk category. The purpose of this study is to further refine SBST risk categorization for predicting improvements in functional disability with attention toward patient level factors that might guide SBST use in routine outpatient physical therapy practice. This was a retrospective cohort study that took place within a large academic, tertiary-care health system. The study cohort consisted of 1,169 patients with LBP who completed a course of outpatient physical therapy from June 1, 2014 to May 31, 2015 and who completed the patient-reported SBST and modified low back pain disability questionnaire (MDQ) questionnaires as part of standard of care. Improvement in functional disability defined as decrease in 10 or more points in the MDQ. Multivariable logistic regression was performed to evaluate independent predictors of improvement after PT, which included SBST risk category, baseline MDQ, a two-way interaction term between SBST category and baseline MDQ, prior level of function (independent vs. required assistance), demographic characteristics, number of completed PT visits, and duration of PT episode of care. In exploratory analyses, additional two-way interaction terms between SBST category and the significant predictors were added to the regression model. Mean age of patients in the study cohort was 55.1 years (SD 16.1); 657 (56.2%) were female, 117 (10.0%) were black race, 127 (10.9%) had Medicaid insurance, and 353 (30.2%) had previously received PT for back pain. In all, 35.8% (n=419) patients categorized as low risk SBST category, 40.7% (n=476) medium risk SBST category, and 23.4% (n=274) high risk SBST category. There was an interaction between baseline MDQ and SBST risk category and improvement with PT. For all three SBST categories, higher baseline MDQ was associated with higher probability of improvement, but the effect was less pronounced as SBST risk category increased. Additional factors independently associated with reduced odds of improvement after PT included black race (odds ratio [OR] 0.44, 95% confidence interval [CI] 0.28-0.72), Medicaid insurance (OR=0.58, 95% CI 0.36-0.95), and prior PT (OR=0.48, 95% CI 0.34-0.67). In exploratory analyses, there was a significant interaction between insurance type and SBST risk category in predicting functional improvement after PT. Patients with Medicare and Medicaid insurance had similar rates of improvement in low and high risk SBST categories but different rates of improvement in the medium risk categories. The SBST tool predicts outcomes of PT in a cohort of patients receiving outpatient PT for LBP. The odds of improvement varied according to baseline disability and SBST risk status. Race, insurance type, and history of previous PT influenced prediction independent of SBST risk status. Incorporating these variables and the interaction between SBST and baseline disability in outcome models has the potential to refine prediction of outcomes after PT.

Sections du résumé

BACKGROUND CONTEXT
The STarT Back Screening Tool (SBST) categorizes risk of future disability in patients with low back pain (LBP). Previous studies evaluating the use of SBST in physical therapy (PT) populations do not reflect the ethnic and socioeconomic diversity occurring in clinical practice and lack statistical power to evaluate factors associated with outcomes within each SBST risk category.
PURPOSE
The purpose of this study is to further refine SBST risk categorization for predicting improvements in functional disability with attention toward patient level factors that might guide SBST use in routine outpatient physical therapy practice.
STUDY DESIGN/SETTING
This was a retrospective cohort study that took place within a large academic, tertiary-care health system.
PATIENT SAMPLE
The study cohort consisted of 1,169 patients with LBP who completed a course of outpatient physical therapy from June 1, 2014 to May 31, 2015 and who completed the patient-reported SBST and modified low back pain disability questionnaire (MDQ) questionnaires as part of standard of care.
OUTCOME MEASURES
Improvement in functional disability defined as decrease in 10 or more points in the MDQ.
METHODS
Multivariable logistic regression was performed to evaluate independent predictors of improvement after PT, which included SBST risk category, baseline MDQ, a two-way interaction term between SBST category and baseline MDQ, prior level of function (independent vs. required assistance), demographic characteristics, number of completed PT visits, and duration of PT episode of care. In exploratory analyses, additional two-way interaction terms between SBST category and the significant predictors were added to the regression model.
RESULTS
Mean age of patients in the study cohort was 55.1 years (SD 16.1); 657 (56.2%) were female, 117 (10.0%) were black race, 127 (10.9%) had Medicaid insurance, and 353 (30.2%) had previously received PT for back pain. In all, 35.8% (n=419) patients categorized as low risk SBST category, 40.7% (n=476) medium risk SBST category, and 23.4% (n=274) high risk SBST category. There was an interaction between baseline MDQ and SBST risk category and improvement with PT. For all three SBST categories, higher baseline MDQ was associated with higher probability of improvement, but the effect was less pronounced as SBST risk category increased. Additional factors independently associated with reduced odds of improvement after PT included black race (odds ratio [OR] 0.44, 95% confidence interval [CI] 0.28-0.72), Medicaid insurance (OR=0.58, 95% CI 0.36-0.95), and prior PT (OR=0.48, 95% CI 0.34-0.67). In exploratory analyses, there was a significant interaction between insurance type and SBST risk category in predicting functional improvement after PT. Patients with Medicare and Medicaid insurance had similar rates of improvement in low and high risk SBST categories but different rates of improvement in the medium risk categories.
CONCLUSIONS
The SBST tool predicts outcomes of PT in a cohort of patients receiving outpatient PT for LBP. The odds of improvement varied according to baseline disability and SBST risk status. Race, insurance type, and history of previous PT influenced prediction independent of SBST risk status. Incorporating these variables and the interaction between SBST and baseline disability in outcome models has the potential to refine prediction of outcomes after PT.

Identifiants

pubmed: 30308254
pii: S1529-9430(18)31158-6
doi: 10.1016/j.spinee.2018.10.002
pmc: PMC7341439
mid: NIHMS1566564
pii:
doi:

Types de publication

Evaluation Study Journal Article Research Support, N.I.H., Extramural

Langues

eng

Sous-ensembles de citation

IM

Pagination

645-654

Subventions

Organisme : NCCIH NIH HHS
ID : UG3 AT009790
Pays : United States

Informations de copyright

Copyright © 2018 Elsevier Inc. All rights reserved.

Références

N Engl J Med. 2001 Feb 1;344(5):363-70
pubmed: 11172169
Health Serv Res. 2015 Apr;50(2):398-417
pubmed: 25219917
Am J Public Health. 2003 Mar;93(3):461-6
pubmed: 12604496
Spine (Phila Pa 1976). 2009 Sep 1;34(19):2077-84
pubmed: 19675510
Phys Ther. 2013 Mar;93(3):321-33
pubmed: 23125279
Pain. 2002 Dec;100(3):291-8
pubmed: 12468000
J Am Acad Orthop Surg. 2004 Mar-Apr;12(2):106-15
pubmed: 15089084
J Musculoskelet Pain. 2011 Jan;19(1):24-30
pubmed: 21731407
J Pain. 2003 May;4(4):176-83
pubmed: 14622701
Phys Ther. 2011 May;91(5):722-32
pubmed: 21451094
Pain Manag. 2012 May;2(3):219-230
pubmed: 23687518
Phys Ther. 1997 Feb;77(2):145-54
pubmed: 9037215
JAMA. 2003 Nov 12;290(18):2443-54
pubmed: 14612481
Arthritis Rheum. 2008 May 15;59(5):632-41
pubmed: 18438893
Arch Intern Med. 2009 Feb 9;169(3):251-8
pubmed: 19204216
J Orthop Sports Phys Ther. 1998 Mar;27(3):219-30
pubmed: 9513868
J Orthop Sports Phys Ther. 2017 Sep;47(9):588-592
pubmed: 28859589
J Pain. 2017 Jan;18(1):54-65
pubmed: 27765643
Phys Ther. 2002 Jan;82(1):8-24
pubmed: 11784274
Phys Ther. 2008 Sep;88(9):989-1004
pubmed: 18689610
Phys Ther. 2001 Feb;81(2):776-88
pubmed: 11175676
Lancet. 2011 Oct 29;378(9802):1560-71
pubmed: 21963002
Ann Intern Med. 2017 Apr 4;166(7):514-530
pubmed: 28192789
Lancet. 1999 Aug 14;354(9178):581-5
pubmed: 10470716
Man Ther. 2010 Apr;15(2):135-41
pubmed: 20036180
Man Ther. 2012 Oct;17(5):385-401
pubmed: 22421188
Lancet. 2018 Jun 9;391(10137):2356-2367
pubmed: 29573870
Pain Pract. 2014 Jul;14(6):532-40
pubmed: 23889982
J Clin Epidemiol. 2009 Aug;62(8):781-796.e1
pubmed: 19136234
J Chiropr Med. 2008 Dec;7(4):161-3
pubmed: 19646379
Lancet. 2018 Jun 9;391(10137):2368-2383
pubmed: 29573872
Aust J Physiother. 2005;51(4):270
pubmed: 16358452
Man Ther. 2009 Feb;14(1):3-12
pubmed: 18511329
AMIA Annu Symp Proc. 2011;2011:683-92
pubmed: 22195124
Spine (Phila Pa 1976). 2007 Mar 1;32(5):586-92
pubmed: 17334295
Phys Ther. 2015 Aug;95(8):1120-34
pubmed: 25858972
Man Ther. 2012 Aug;17(4):336-44
pubmed: 22534654
Arch Phys Med Rehabil. 2018 Aug;99(8):1533-1539.e2
pubmed: 29625095
J Orthop Sports Phys Ther. 2014 Sep;44(9):656-64
pubmed: 25098194

Auteurs

Irene L Katzan (IL)

Neurological Institute Center for Outcomes Research & Evaluation, Neurological Institute, Cleveland Clinic, 9500 Euclid Avenue, Cleveland Ohio 44195, USA. Electronic address: katzani@ccf.org.

Nicolas R Thompson (NR)

Neurological Institute Center for Outcomes Research & Evaluation, Neurological Institute, Cleveland Clinic, 9500 Euclid Avenue, Cleveland Ohio 44195, USA.

Steven Z George (SZ)

Duke Clinical Research Institute and Department of Orthopaedic Surgery, Duke University, 2400 Pratt Street, Room 0311 Terrace Level, Durham NC 27705, USA.

Sandi Passek (S)

Department of Physical Medicine & Rehabilitation, Neurological Institute, Cleveland Clinic, 9500 Euclid Avenue, Cleveland Ohio 44195, USA.

Frederick Frost (F)

Department of Physical Medicine & Rehabilitation, Neurological Institute, Cleveland Clinic, 9500 Euclid Avenue, Cleveland Ohio 44195, USA.

Mary Stilphen (M)

Department of Physical Medicine & Rehabilitation, Neurological Institute, Cleveland Clinic, 9500 Euclid Avenue, Cleveland Ohio 44195, USA.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH